JUVÉDERM® VOLUX™ XC FOR IMPROVEMENT OF JAWLINE DEFINITION NOW AVAILABLE NATIONWIDE
Go back to JUVÉDERM® VOLUX™ XC FOR IMPROVEMENT OF JAWLINE DEFINITION NOW AVAILABLE NATIONWIDE| AbbVie (NYSE: ABBV) | Delayed: 250.33 +0.87 (0.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $249.46 | 52 Week High | $68.12 | |||
| Open | $249.49 | 52 Week Low | $50.71 | |||
| Day High | $251.49 | P/E | 54.30 | |||
| Day Low | $248.31 | EPS | $4.61 | |||
| Volume | 4,648,637 | |||||

